SonoThera™ to Present Preclinical Data on Use of Its Ultrasound-Guided Gene Therapy Platform at the 2023 ASGCT Annual Meeting

SOUTH SAN FRANCISCO, Calif., May 11, 2023 /PRNewswire/ -- SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, today announced they will present preclinical data related to the use of their nonviral ultrasound-guided gene...

Click to view original post